Skip to main content
Log in

Some properties of a plasminogen activating factor in human breast cancer cytosol and its relation to steroid receptors

  • Scandinavian Breast Cancer Symposium
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

A plasminogen activating factor has been isolated and partially characterized in low salt cytosol from human breast cancer. The activity can be precipitated with 40% saturated ammonium sulphate as a high molecular weight aggregate (MW approximately 500,000). The aggregate dissociates in high salt buffer, and chromatography on Sephacryl S-300 or sucrose density gradient centrifugation in 400 mM KCl buffer gives a molecular weight of approximately 55,000. The substance binds with high affinity to lysine-Sepharose and can be eluted from lysine-Sepharose columns with 1.5M NaCl. Affinity chromatography on lysine-Sepharose separates the activator from plasminogen and from inhibitors of plasminogen activation. The activator is irreversibly inhibited by 2 mM DFP (di-isopropyl-fluorophosphate).

The plasminogen activating activity (PAA) measured in ammonium sulphate precipitates or affinity column eluates from separate cytosols shows a significant correlation with concentrations of estradiol and progesterone receptors in the corresponding cytosols. The presence of PAA seems to be strictly dependent on the simultaneous presence of progesterone receptor in the tumor, and discriminates sharply between PgR positive and negative tumors, irrespective of estrogen receptor status.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Quigley J: Proteolytic enzymes in normal and malignant cells.In RO Hynes (ed). Surfaces of Normal and Malignant Cells. J Wiley & Sons, Chichester, UK, 1979, pp 247–285.

    Google Scholar 

  2. Christman JK, Silverstein SC, Acs G: Plasminogen activators.In AJ Barrett (ed). Proteinases in Mammalian Cells and Tissues. North Holland, Amsterdam, 1979, pp 91–149.

    Google Scholar 

  3. McCabe RP, Evans CH: Plasminogen activator, fibronectin, lymphotoxin sensitivity and natural skin reactivity. Relationships to guinea pig cell tumorigenicity. J Natl Cancer Inst 68: 329–335, 1982.

    Google Scholar 

  4. Goldfarb RH, Quigley JP: Synergistic effect of tumor virus transformation and tumor promoter treatment on the production of plasminogen activator by chick embryo fibroblasts. Cancer Res 38: 4601–4609, 1978.

    Google Scholar 

  5. Wigler M, Weinstein IB: Tumor promoter induces plasminogen activator. Nature 259: 232–233, 1976.

    Google Scholar 

  6. Hozumi M, Ogawa M, Sugimura T, Takeuchi T, Umezawa H: The inhibition of tumorigenesis in mouse skin by leupeptin, a protease inhibitor from Actinomycetes. Cancer Res 32: 1725–1729, 1972.

    Google Scholar 

  7. Troll W, Karlsen A, Janoff A: Tumorigenesis in mouse skin: Inhibition by synthetic inhibitors of proteases. Science 169: 1211–1213, 1970.

    Google Scholar 

  8. Kennedy AR, Weichelbaum RR: Effects of 17-beta estradiol on radiation transformation in vitro. Inhibition of effects by protease inhibitors. Carcinogenesis 2: 67–69, 1981.

    Google Scholar 

  9. Evers JL, Jashbhai P, Madeja JM, Schneider SL, Hobika GH, Camiolo SM, Markus G: Plasminogen activator activity and composition in human breast cancer. Cancer Res 42: 219–226, 1982.

    Google Scholar 

  10. Nagy B, Ban J, Brdar B: Fibrinolysis associated with human neoplasia: Production of plasminogen activators by human tumors. Int J Cancer 19: 614–620, 1977.

    Google Scholar 

  11. Ossowski L, Niegel D, Reich E: Mammary plasminogen activator: Correlation with evolution, hormonal modulation and comparison between normal and neoplastic tissue. Cell 16: 929–940, 1979.

    Google Scholar 

  12. Mark TW, Rutledge G, Sutherland DJ: Androgen dependent fibrinolytic activity in mouse mammary carcinoma (Shionogi SC 115) cells in vitro. Cell 7: 223–226, 1976.

    Google Scholar 

  13. Butler WB, Kirkland WL, Jorgensen TL: Induction of plasminogen activator by estrogen in a human breast cancer cell line (MCF-7). Biochem Biophys Res Commun 90: 1328–1334, 1979.

    Google Scholar 

  14. Wilson EL, Dutlow C, Dowdle EB: Characterization of a new hormonally responsive human breast carcinoma cell line (Abstract).In Growth of Cells in Hormonally Defined Media, September 1–4, 1981, Cold Spring Harbour, New York, p 101.

    Google Scholar 

  15. Sherman MS, Tuazon FB, Miller LK: Estrogen receptor cleavage and plasminogen activation by enzymes in human breast cancer cytosol. Endocrinology 106: 1715–1727, 1980.

    Google Scholar 

  16. Sutherland DJ: Plasminogen activating activity: Association with steroid binding by cytosols of human breast cancer. J Natl Cancer Inst 64: 3–7, 1980.

    Google Scholar 

  17. Thorsen T: Association of plasminogen activator activity and steroid receptors in human breast cancer. J Steroid Biochem 18: 129–132, 1982.

    Google Scholar 

  18. McGuire WL, Horwitz KG, Chamness GC, Zava DT: A physiological role for estrogen and progesterone receptors in breast cancer. J Steroid Biochem 7: 875–882, 1976.

    Google Scholar 

  19. Overwien B, Neumann C, Sorge C: Detection of plasminogen activator in macrophage culture supernatants by a photometric assay. Hoppe-Seylers Z Physiol Chem 361: 1251–1255, 1980.

    Google Scholar 

  20. Radcliffe R, Heinze T: Isolation of plasminogen activator from human plasma by chromatography on lysine-Sepharose. Arch Biochem Biophys 189: 185–194, 1978.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thorsen, T. Some properties of a plasminogen activating factor in human breast cancer cytosol and its relation to steroid receptors. Breast Cancer Res Tr 2, 385–390 (1982). https://doi.org/10.1007/BF01805880

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01805880

Keywords

Navigation